학술논문
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
Document Type
Journal Article
Author
Lê, Minh P; Chaix, Marie-Laure; Chevret, Sylvie; Bertrand, Julie; Raffi, François; Gallien, Sébastien; Abbassi, El Mountacer Billah El; Katlama, Christine; Delobel, Pierre; Yazdanpanah, Yazdan; Lê, Minh P; Raffi, François; Gallien, Sébastien; El Abbassi, El Mountacer Billah; Saillard, Juliette; Molina, Jean-Michel; Peytavin, Gilles; ANRS 165 DARULIGHT Study Group
Source
Subject
*PHARMACOKINETICS
*DARUNAVIR
*RITONAVIR
*VIROLOGY
*HIV-positive persons
*BLOOD plasma
*COMBINATION drug therapy
*COMPARATIVE studies
*HIV infections
*RESEARCH methodology
*MEDICAL cooperation
*RESEARCH
*SEMEN
*EVALUATION research
*HIV protease inhibitors
*REVERSE transcriptase inhibitors
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0305-7453
Abstract